Skip to main content

Aspira Women's Health, Inc. (AWH)

NASDAQ: AWH · IEX Real-Time Price · USD
3.26 0.03 (0.93%)
Oct 25, 2021 4:00 PM EDT - Market closed
Market Cap360.86M
Revenue (ttm)5.98M
Net Income (ttm)-23.36M
Shares Out111.96M
EPS (ttm)-0.22
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume117,056
Open3.21
Previous Close3.23
Day's Range3.17 - 3.28
52-Week Range2.98 - 10.54
Beta3.05
Analystsn/a
Price Targetn/a
Est. Earnings DateNov 11, 2021

About AWH

Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women in the United States. It provides OVA1, Overa, and Ova1PLUS to detect the risk of ovarian malignancy. The company also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, it owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address crit...

IndustryHealth Care Equipment & Supplies
Founded1993
CEOValerie Palmieri
Employees69
Stock ExchangeNASDAQ
Ticker SymbolAWH
Full Company Profile

Financial Performance

In 2020, AWH's revenue was $4.65 million, an increase of 2.49% compared to the previous year's $4.54 million. Losses were -$17.91 million, 17.5% more than in 2019.

Financial Statements

News

Aspira Women's Health Executes Four Aspira SynergyTM Technology Transfer Agreements

Aspira Women's Health has entered into partnership agreements with two of the largest U.S.-based women's health networks and two independent U.S. laboratories. Aspira Women's Health has entered into par...

3 weeks ago - GlobeNewsWire

Aspira Women's Health Inc. to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference

AUSTIN, Texas, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health, Inc. (Nasdaq: AWH), a bioanalytical-based women's health company, today announced that it will present at the Cantor Fitzgerald V...

1 month ago - GlobeNewsWire

Aspira Women's Health Kicks Off Ovarian Cancer Awareness Month by Further Establishing Itself as a Thought Leader in ...

Signals Call to Action for Immediate Progress in Conquering Ovarian Cancer Signals Call to Action for Immediate Progress in Conquering Ovarian Cancer

1 month ago - GlobeNewsWire

Aspira (AWH) Reports Q2 Loss, Tops Revenue Estimates

Aspira (AWH) delivered earnings and revenue surprises of 0.00% and 5.82%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Aspira Women's Health Reports Second Quarter 2021 Financial Results

 Total Revenue Increased 141% to $1.8 million; OVA1 Volume Grew 85% to 4,553 Accessions

2 months ago - GlobeNewsWire

Analysts Estimate Aspira (AWH) to Report a Decline in Earnings: What to Look Out for

Aspira (AWH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

Aspira Women's Health Inc. to Report Second Quarter 2021 Financial Results on August 12

AUSTIN, Texas, July 27, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health, Inc. (Nasdaq: AWH), a bioanalytical-based women's health company, today announced that it will report financial results for the se...

2 months ago - GlobeNewsWire

Aspira Women's Health (AWH) is Oversold: Can It Recover?

Aspira Women's Health (AWH) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

3 months ago - Zacks Investment Research

UPDATE -- Aspira Women's Health Inc. Announces Coverage for OVA1® in the AIM Specialty Health Laboratory Medicine Cli...

AUSTIN, Texas, July 08, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (Nasdaq: AWH) today announced its OVA1® risk assessment test for ovarian cancer in women with pelvic masses is considered medi...

3 months ago - GlobeNewsWire

Aspira Women's Health Inc. to Participate in the William Blair Growth Stock Conference

AUSTIN, Texas, May 19, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health, Inc. (Nasdaq: AWH), a bioanalytical-based women's health company, today announced that management will participate in and present a...

5 months ago - GlobeNewsWire

Aspira (AWH) Reports Q1 Loss, Tops Revenue Estimates

Aspira (AWH) delivered earnings and revenue surprises of 79.17% and 6.86%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

Aspira Women's Health Reports First Quarter 2021 Financial Results

Conference call scheduled for today, May13 at 4:30 p.m. ET Conference call scheduled for today, May13 at 4:30 p.m. ET

5 months ago - GlobeNewsWire

Aspira Women's Health, Inc. Expands Leadership Team with Industry Veteran

New Team Addition Is a Thought Leader in Reimbursement and Diagnostics New Team Addition Is a Thought Leader in Reimbursement and Diagnostics

5 months ago - GlobeNewsWire

Earnings Preview: Aspira (AWH) Q1 Earnings Expected to Decline

Aspira (AWH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

5 months ago - Zacks Investment Research

What Traders Can Expect From Small Caps in 2021

Below is a repost of an article from Benzina.com, which features Schaeffer's V.P.

Other symbols:AASHAKSONOX
6 months ago - Schaeffers Research

Aspira (AWH) Reports Q4 Loss, Tops Revenue Estimates

Aspira (AWH) delivered earnings and revenue surprises of -1350.00% and 11.23%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Aspira Women's Health Reports Fourth Quarter and Full Year 2020 Financial Results

Conference Call scheduled for today, March 25th at 4:30 p.m. ET Conference Call scheduled for today, March 25th at 4:30 p.m. ET

7 months ago - GlobeNewsWire

Aspira Women's Health, Inc. Announces an Agreement for the Development and Commercialization of an Early-Detection Te...

AUSTIN, Texas, March 25, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health, Inc. (Nasdaq: AWH), a bioanalytical-based women's health company, today announced it has entered into an agreement with Dana-Farb...

7 months ago - GlobeNewsWire

Analysts Estimate Aspira (AWH) to Report a Decline in Earnings: What to Look Out for

Aspira (AWH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

7 months ago - Zacks Investment Research

Aspira Women's Health Inc. Appoints Nicole Sandford to its Board of Directors

AUSTIN, Texas, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (Nasdaq: AWH), a bioanalytical-based women's health company, today announced the appointment of Ms. Nicole Sandford to its Boa...

8 months ago - GlobeNewsWire

Aspira Women's Health, Inc. to Participate in BTIG's Virtual MedTech, Digital Health, Life Science and Diagnostic Too...

AUSTIN, Texas, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health, Inc. (Nasdaq: AWH), a bioanalytical-based women's health company, today announced management will participate and present in the 2...

8 months ago - GlobeNewsWire

Aspira Women's Health, Inc. to add NCCN Management Recommendations to its Proprietary Aspira GenetiX™ Clinical Report

Aspira will incorporate Management Recommendations from the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) in the Aspira GenetiX report Aspira...

8 months ago - GlobeNewsWire

Aspira Women's Health Inc. Announces Pricing of $45 Million Public Offering of Common Stock

AUSTIN, Texas, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (Nasdaq: AWH) (“Aspira”), a bio-analytical based women's health company focused on gynecologic disease, today announced the pr...

8 months ago - GlobeNewsWire

Aspira Women's Health Inc. Announces Proposed Public Offering of Common Stock

AUSTIN, Texas, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (Nasdaq: AWH) (“Aspira”), a bio-analytical based women's health company focused on gynecologic disease, today announced it has...

8 months ago - GlobeNewsWire

These Were the 5 Best Diagnostics Stocks of 2020

These winners are positioned for gains even after COVID.

Other symbols:FLGTGNMKNTRACODX
9 months ago - The Motley Fool